ee

Registreeru
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Legend Biotech Corp ADR
Search

Legend Biotech Corp ADR

Suletud

48.19 -10.79

Tugev "osta" hinnang

Hinna uuendus 6. sept 2024, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

48.03

Max

49.48

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+68.77 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

18. nov 2024

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

N/A / 56.63 Toetus ja vastupanu

Legend Biotech Corp ADR Graafik

Seotud uudised

13. mai 2024, 11:36 UTC

Tulu

Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales

DJ

Loe

9. aug 2024, 11:02 UTC

Tulu

Legend Biotech 2Q License Rev Was $90.8M >LEGN

DJ

Loe

9. aug 2024, 11:01 UTC

Tulu

Legend Biotech 2Q Collaboration Rev $93.3M >LEGN

DJ

Loe

9. aug 2024, 11:01 UTC

Tulu

Legend Biotech 2Q Loss/Shr 5c >LEGN

DJ

Loe

9. aug 2024, 11:00 UTC

Tulu

Legend Biotech 2Q Rev $186.5M >LEGN

DJ

Loe

26. juuli 2024, 11:01 UTC

Tulu

Legend Biotech Expects 2H Adjusted Net Loss $94.7M

DJ

Loe

13. mai 2024, 11:02 UTC

Tulu

Legend Biotech 1Q Loss/Shr 16c >LEGN

DJ

Loe

13. mai 2024, 11:02 UTC

Tulu

Legend Biotech 1Q Research and Development Expenses $101.0M >LEGN

DJ

Loe

11. märts 2024, 11:05 UTC

Tulu

Legend Biotech 4Q Loss $144.8M >LEGN

DJ

Loe

11. märts 2024, 11:05 UTC

Tulu

Legend Biotech 4Q Loss/Shr 40c >LEGN

DJ

Loe

11. märts 2024, 11:00 UTC

Tulu

Legend Biotech 4Q Rev $79.5M >LEGN

DJ

Loe

20. nov 2023, 11:01 UTC

Tulu

Legend Biotech 3Q Research and Development Expenses $95.9M >LEGN

DJ

Loe

20. nov 2023, 11:01 UTC

Tulu

Legend Biotech 3Q Loss/Shr 17c >LEGN

DJ

Loe

20. nov 2023, 11:00 UTC

Tulu

Legend Biotech 3Q Rev $96M >LEGN

DJ

Loe

21. sept 2023, 12:00 UTC

Peamised uudised

Blockbuster Cancer Treatment Stymied by Supply Chain -- for Now -- Heard on the Street -- WSJ

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Legend Biotech Corp ADR Prognoos

Hinnasiht

By TipRanks

68.77% tõus

12 kuu keskmine prognoos

Keskmine 81.5 USD  68.77%

Kõrge 94 USD

Madal 60 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Legend Biotech Corp ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

11

Osta

1

Hoia

0

Müü

Põhineb 12 analüütiku instrumendi Legend Biotech Corp ADR aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 56.63Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Pikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%